Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79.2M Buy
521,298
+84,499
+19% +$10.3M 0.02% 650
2025
Q4
$47.8M Buy
436,799
+230,429
+112% +$33.5M 0.01% 904
2025
Q3
$29.2M Sell
206,370
-2,187
-1% -$319K 0.01% 1173
2025
Q2
$33.7M Buy
208,557
+19,095
+10% +$2.37M 0.01% 1068
2025
Q1
$20.2M Buy
189,462
+6,736
+4% +$939K 0.01% 1305
2024
Q4
$22.5M Buy
182,726
+2,626
+1% +$370K 0.01% 1257
2024
Q3
$25.8M Buy
180,100
+7,623
+4% +$1.08M 0.01% 1190
2024
Q2
$28.2M Buy
172,477
+53,782
+45% +$6.69M 0.01% 1070
2024
Q1
$14.8M Sell
118,695
-273,145
-70% -$28.9M ﹤0.01% 1494
2023
Q4
$29.4M Buy
391,840
+189,291
+93% +$11.1M 0.01% 1051
2023
Q3
$10.8M Buy
+202,549
New +$11.2M ﹤0.01% 1633

Other funds holding ARM

Ameriprise's ARM Position: Q1 2026 in Review

Ameriprise increased its Arm (ARM) stake by 19% in Q1 2026, buying an estimated $10.3M and bringing the position to 521,298 shares worth $79.2M. The position accounts for 0.02% of the portfolio, ranked #650.

Ameriprise first reported a position in ARM in Q3 2023 and has held it in 11 quarters since. 742 funds tracked by Wall St. Rank hold ARM as of Q1 2026.

  • Ameriprise held 521,298 shares of Arm worth $79.2M as of Q1 2026.
  • Ameriprise bought 84,499 Arm shares in Q1 2026, an estimated $10.3M.
  • Arm made up 0.02% of Ameriprise's portfolio in Q1 2026, its #650 holding.
  • Ameriprise first reported a position in Arm in Q3 2023 and has held it in 11 quarters since.
  • 742 funds tracked by Wall St. Rank held Arm as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.